Table 1—

Baseline characteristics

Lipodystrophic subjectsPCOS subjectsType 2 diabetic subjectsControl subjectsP
n6101219
Age (years)47 ± 1331 ± 656 ± 14*41 ± 11<0.001
Mean arterial pressure (mmHg)96 ± 894 ± 9108 ± 1398 ± 12>0.2
BMI (kg/m2)27 ± 330 ± 531 ± 726 ± 7>0.2
Total cholesterol (mg/dl)200 ± 47192 ± 31178 ± 37172 ± 13>0.2
LDL cholesterol (mg/dl)101 ± 31120 ± 2699 ± 4098 ± 23>0.2
HDL cholesterol (mg/dl)34 ± 837 ± 949 ± 1461 ± 12<0.001
Triglycerides (mg/dl)311 ± 165171 ± 72*153 ± 9570 ± 39<0.001
Insulin (μU/ml)58 ± 85*28 ± 2214 ± 1210 ± 80.016
Glucose (mg/dl)191 ± 11388 ± 9156 ± 6888 ± 18<0.001
HOMA-IR27.6 ± 16.46.6 ± 1.9*6.1 ± 1.4*2.3 ± 0.40.001
Adiponectin (μg/ml)16.1 ± 13.58.3 ± 4.29.0 ± 3.813.4 ± 5.80.041
Free fatty acids (mEq/l)0.15 ± 0.060.19 ± 0.05*0.20 ± 0.070.11 ± 0.050.002
CRP (mg/l)2.25 ± 1.611.49 ± 1.123.74 ± 4.091.54 ± 2.26>0.2
  • Data are means ± SD.

  • * P < 0.05 vs. control subjects;

  • P < 0.01.